This inventor holds 4 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1994-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994-1996
Title: Akihiko Fujie: Innovator in Antimicrobial Compounds
Introduction
Akihiko Fujie is a notable inventor based in Tsuchiura, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimicrobial compounds. With a total of 4 patents to his name, Fujie's work has the potential to impact the treatment of infectious diseases.
Latest Patents
Fujie's latest patents include a novel polypeptide with excellent fungicidal and protozoicidal effects. This invention, identified as WF11243, showcases his innovative approach to combating microbial threats. Additionally, he has developed an antimicrobial polypeptide compound that can be utilized in pharmaceutical compositions. This compound has a specific general formula and is designed to treat infectious diseases caused by pathogenic microorganisms.
Career Highlights
Fujie is currently associated with Fujisawa Pharmaceutical Company, Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving health outcomes through innovative solutions.
Collaborations
Fujie has collaborated with esteemed colleagues such as Masakuni Okuhara and Toshiro Iwamoto. These partnerships have likely contributed to the success of his inventions and the advancement of their shared goals in pharmaceutical research.
Conclusion
Akihiko Fujie stands out as a dedicated inventor in the pharmaceutical industry, with a focus on antimicrobial compounds. His contributions are paving the way for new treatments that could significantly benefit public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
